Boyu Capital Investment Management Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
+$3.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$65.1M |
| 2 |
YSG
Yatsen Holding
YSG
|
+$11.8M |
| 3 |
VIE
Viela Bio, Inc. Common Stock
VIE
|
+$10.8M |
| 4 |
MINISO
MNSO
|
+$8.71M |
| 5 |
VNET
VNET Group
VNET
|
+$3.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 67.87% |
| 2 | Healthcare | 0.4% |
| 3 | Consumer Discretionary | 0% |
| 4 | Consumer Staples | 0% |
| 5 | Technology | 0% |
Similar funds
Boyu Capital Investment Management Company's Q1 2021 Portfolio in Review
As of Q1 2021, Boyu Capital Investment Management Company held 12 positions worth $496M, down 8.9% from $544M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Boyu Capital Investment Management Company withdrew a net $272M in Q1 2021, closing 6 positions. Its most notable exit was Pinduoduo, an estimated $65.1M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 68% of assets, up from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Boyu Capital Investment Management Company opened a new position in Gracell Biotechnologies Inc. American Depositary Shares worth $1.97M.
- Boyu Capital Investment Management Company's largest Q1 2021 buy was Gracell Biotechnologies Inc. American Depositary Shares: 127,605 shares worth $1.97M.
- Boyu Capital Investment Management Company fully exited Pinduoduo in Q1 2021, selling an estimated $65.1M.
- Boyu Capital Investment Management Company's ten largest holdings make up 100% of its $496M portfolio in Q1 2021.
- Boyu Capital Investment Management Company opened 1 new position and closed 6 in Q1 2021.
- Boyu Capital Investment Management Company's portfolio value fell 8.9% quarter-over-quarter to $496M.
Based on Boyu Capital Investment Management Company's 13F filing for Q1 2021, filed 17 May 2021.